ArticleCell biochemistry and biophysics2026
Investigating the Effect of Low Molecular Weight Heparin, Enoxaparin, on Pentylenetetrazole (PTZ)-Induced Neuronal Damage in C6 and HT-22 Cell Lines.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In this study, the effect of Enoxaparin, a type of low molecular weight heparin (LMWH), on neuronal damage caused by pentylenetetrazol (PTZ)-induced epileptic seizures was investigated. The study utilized C6 and HT-22 cell lines, and the extent to which enoxaparin influenced cytotoxicity in these cells will be evaluated. For this purpose, four groups were established: a control group, a group exposed to PTZ, a group treated with enoxaparin, and a group treated with both PTZ and enoxaparin. Cell viability was measured using a 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2 H-tetrazolium-5-carboxanilide (XTT) assay. To evaluate the effects of enoxaparin administration on oxidative stress levels in cell lysates after PTZ-induced neuronal injury, total antioxidant (TAS) and total oxidant (TOS) levels were measured colorimetrically in both cell lines. Mouse nitric oxide (NO), neuronal nitric oxide synthase (nNOS) and rat inducible nitric oxide synthase (iNOS) commercial sandwich ELISA kits were used to measure the effects of enoxaparin on the nitric oxide pathway in cell lysates. As a result of normalization and evaluation of XTT data, it was observed that the viability rate of the group treated with PTZ only decreased to 60% in both cell lines. The results showed that PTZ caused cell damage by increasing oxidative stress and disrupting signaling in neurons. Enoxaparin treatment prevented cytotoxicity by increasing antioxidant capacity and exhibited a neuroprotective effect by suppressing the inflammatory response.
Indexed as
Identifiers
41134472What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.